Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 66.49
+2.81 (4.41%)
Aug 13, 2025, 2:45 PM CST
Oncternal Therapeutics Market Cap
SHA:688399 has a market cap or net worth of 5.57 billion as of August 13, 2025. Its market cap has increased by 37.61% in one year.
Market Cap
5.57B
Enterprise Value
3.99B
Revenue
347.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
$66.49
Market Cap Chart
Since December 5, 2019, SHA:688399's market cap has increased from 3.22B to 5.57B, an increase of 73.14%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.34B | 43.32% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | 11.27B | 232.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 407.67B |
| Shenzhen Mindray Bio-Medical Electronics | 283.36B |
| WuXi AppTec | 267.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.37B |
| Aier Eye Hospital Group | 120.66B |
| Sichuan Biokin Pharmaceutical | 118.80B |
| Shanghai United Imaging Healthcare | 107.16B |
| Yunnan Baiyao Group Co.,Ltd | 99.83B |